Full-Time
Chief Accountant
PaxeraHealth
51-200 employees
Enterprise imaging with AI-driven PACS platform
No salary listed
Newton, MA, USA
Hybrid
Hybrid position; residence in Massachusetts is required.
Bachelor's
 Accounting (1) |
|---|
Get referred to PaxeraHealth
See people who can refer or advise you
- A Bachelor's degree in Accounting or Finance is required.
- A minimum of 5 years of accounting experience is required.
- Hands-on experience with QuickBooks Online is required.
- Knowledge of U.S. GAAP and SaaS revenue recognition principles is required.
- Experience with multi-currency and multi-entity accounting is required.
- Experience with general ledger, accounts payable, accounts receivable, payroll coordination, bank reconciliations, financial reporting, audits, tax filings, regulatory reporting, internal controls, and accounting process documentation is required.
- Advanced proficiency in Excel and accounting software is required.
- Strong analytical and problem-solving skills are required.
- Excellent written and verbal communication skills are required.
- Exceptional attention to detail and organizational skills are required.
- Ability to manage multiple priorities in a fast-paced environment is required.
- Oversee daily accounting activities, including the general ledger, accounts payable, accounts receivable, payroll coordination, and bank reconciliations.
- Manage accurate and timely monthly, quarterly, and annual close processes.
- Maintain the chart of accounts and accounting policies in accordance with U.S. GAAP.
- Prepare and review financial statements and management reports.
- Ensure compliance with U.S. GAAP, internal policies, and applicable healthcare regulations.
- Support audits, tax filings, and regulatory reporting.
- Develop and maintain internal controls to safeguard company assets.
- Identify opportunities to improve workflows, automation, and efficiency.
- Ensure strong documentation and audit trails across accounting processes.
- Partner closely with the CFO, Controller, and executive leadership.
- Provide insights on revenue recognition, contracts, projects, and operational performance.
- Mentor and support accounting team members as needed.
- Support accounting for medical imaging solutions, software licensing, services, and long-term projects.
- Assist with multi-currency transactions, international entities, and intercompany accounting.
- Collaborate with operations and project teams to ensure accurate cost and revenue alignment.
PaxeraHealth builds enterprise imaging and AI software for healthcare. Its core platform combines PACS and VNA functionality with native AI to unify imaging from multiple modalities, offering a zero-footprint viewer accessible via browser or mobile. It also provides Algorithms as a Service and ARK, a no-code AI authoring platform that lets facilities create, validate, and deploy multimodal AI models using their own data without programming. The company differentiates itself with AI-focused tools, the no-code AI platform, and scalable, cost-effective solutions for radiology, cardiology, mammography, veterinary, and dental imaging, distributed through direct sales and partners, with a goal to improve diagnostic accuracy, automate workflows, and broaden access to AI-enabled imaging across 45 countries.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Boston, Massachusetts
Founded
2009
Get referred to PaxeraHealth
See people who can refer or advise you
Simplify's Take
What believers are saying
- RAK Hospital partnered with PaxeraHealth in May 2026 for AI-powered enterprise imaging.
- Germany launch and ADR distribution expanded European reach during May and March 2026.
- USPTO registered VNAi in 2026, strengthening product branding and commercial defensibility.
What critics are saying
- GE HealthCare, Philips, Siemens, and Sectra dominate enterprise imaging buying decisions.
- PaxeraHealth still relies on external capital after 2022 Series A and 2025 RevTek financing.
- A PACS outage or HIPAA breach would kill renewals and trigger contract terminations.
What makes PaxeraHealth unique
- ARK lets hospitals build imaging AI without coding or outside data scientists.
- Vibe Imaging fuses natural-language workflow orchestration with real-time AI for radiologists.
- PaxeraHealth sells globally, with 2026 launches in Germany and partnerships in the UAE.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Paid Vacation
Paid Sick Leave
Paid Holidays
401(k) Company Match
Remote Work Options
Company News
CARPL.ai Partners with Enlitic to accelerate AI validation for imaging customers. CUPERTINO, Calif., June 10, 2026 (GLOBE NEWSWIRE) - CARPL.ai, the world's largest radiology AI marketplace and enterprise platform, today announced a partnership with Enlitic, to give imaging customers a stronger approach to AI validation by improving how imaging data can be used for evaluation. Through its Ensight platform, Enlitic helps structure and normalize imaging data for AI validation workflows. For CARPL, that adds value to a platform built to help customers discover, explore, validate, and deploy imaging AI through a single environment. This matters because one of the biggest barriers to AI adoption in addition to access to algorithms, is access to data ready for meaningful evaluation. In many healthcare organizations, imaging data is fragmented across systems, inconsistent, and difficult to search at scale. As a result, teams may spend significant time identifying the right studies and preparing data before evaluation can begin. By helping organize imaging data earlier in the process, Enlitic Ensight supports a more efficient path to validation within the CARPL platform. That can help healthcare organizations reduce delays, compare AI solutions more effectively, and move toward deployment with greater confidence. "Data fragmentation remains a barrier to scaling AI in radiology," said Vidur Mahajan, CEO of CARPL.ai. "Our work with Enlitic ensures healthcare institutions can accelerate imaging AI validation with confidence before deployment, ultimately driving safer, more reliable patient care." "Too often, validation slows down because teams cannot quickly find and prepare the right data," said Michael Sistenich, CEO. "By supporting CARPL with more structured and searchable imaging data, we are helping create a faster, more practical path to AI adoption." As healthcare organizations continue to evaluate AI more rigorously, the ability to validate earlier and more effectively will become even more important. This partnership helps CARPL offer customers a stronger way to move from AI exploration to real-world use. About Enlitic Enlitic is a software company that uses artificial intelligence to develop software products that manage medical imaging data in radiology such as MRI, CT scans, X-ray and ultrasound images and licenses such products to healthcare providers. Enlitic's products, including its current product offering and product suite under development, seek to standardize, protect, integrate, and analyze data to create the foundation of a real-world evidence platform that can improve clinical workflows, increase efficiencies, and expand capacity. Read more at enlitic.com. About CARPL.ai CARPL.ai is the world's largest radiology AI marketplace and platform offering 250+ applications from 95+ AI Partners. With regulatory clearances across multiple regions that include the FDA, CE, ANVISA, TGA and HSA, CARPL.ai provides a single user interface, a single data channel, and a single procurement channel for the discovery, testing, deployment, and monitoring of AI solutions in clinical practice. The CARPL.ai platform integrates with leading PACS systems, including Agfa HealthCare, DeepHealth, Intelerad, Philips, Ramsoft, Paxera Health, amongst others, ensuring end-to-end interoperability across imaging environments. Learn more at carpl.ai. [email protected] +1-877-365-4842 CARPL.ai and Enlitic are partnering to streamline imaging AI validation by making clinical imaging data more organized, searchable, and ready for evaluation. Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. Advertising Industry Review do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
SUNNYVALE, Calif., July 30, 2024 /PRNewswire/ -- Ferrum Health, an enterprise healthcare AI platform supporting over fifty third-party, industry-leading algorithms, proudly announces a strategic partnership with PaxeraHealth, a global leader in enterprise imaging solutions. This collaboration aims to drive the adoption of artificial intelligence (AI) into native clinical workflows with a modern, turn-key approach.PaxeraHealth is at the forefront of modernizing enterprise imaging architecture, with the introduction of innovations such as VNAi and ARK, the latest version of its industry-first, zero-coding AI development platform. PaxeraHealth's state-of-the-art architecture paired with Ferrum Health's Clinical AI infrastructure, allows for efficient deployments of AI optimized within clinician's native workflows. The alliance promises to deliver forward-thinking solutions that enhance patient care and unlock the potential for clinical AI in practice.Mohammed Shoura CEO of PaxeraHealth, commented, "Our collaboration with Ferrum Health represents a significant milestone in the evolution of AI in medical imaging. By integrating the Ferrum Health Enterprise AI Platform into our enterprise imaging solution suite, we are able to offer a commercial pathway for provider developed AI and expedite the adoption of commercially available AI within imaging workflows. This partnership underscores our commitment to innovation and excellence in healthcare technology."Ferrum Health's platform is renowned for its focus on data security, providing secure containers for third-party applications to be deployed locally within the client's existing architecture
PaxeraHealth has closed a series A funding round led by Sopris Capital.
PaxeraHealth Closes Series A Funding Back to HomeBOSTON, MA, PaxeraHealth, a medical imaging and AI developer, announced the close of its series A financing round led by Sopris Capital.PaxeraHealth, a medical imaging and AI developer, announced the close of its series A financing round led by Sopris Capital, a venture capital firm focused on technology-enabled healthcare solutions.PaxeraHealth Corp. is a medical imaging platform developer based in Boston, MA that designs next generation technology to automate clients' workflow, elevate patient care and improve clinical, financial, and operational outcomes.(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page
PaxeraHealth Corp is pleased to announce that the University of Pennsylvania has selected PaxeraHealth’s zero-coding authoring platform to assist in their development of new imaging AI algorithms.